Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. Sareum Holdings plc
  6. News
  7. All News
    SAR   GB00B02RFS12

SAREUM HOLDINGS PLC

(SAR)
  Report
Delayed Quote. Delayed London Stock Exchange - 10/18 11:35:09 am
6.9 GBX   +9.52%
10/07SAREUM : US Patent Granted for SDC-1802 TYK2/JAK1 Inhibitor
PU
09/29SAREUM : Reference to SRA737 Timeline at Cantor Conference
PU
07/30SAREUM : Shares Jump 8% on Incoming Cancer Treatment Patent
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
All news about SAREUM HOLDINGS PLC
10/07SAREUM : US Patent Granted for SDC-1802 TYK2/JAK1 Inhibitor
PU
09/29SAREUM : Reference to SRA737 Timeline at Cantor Conference
PU
07/30SAREUM : Shares Jump 8% on Incoming Cancer Treatment Patent
MT
07/30SAREUM : Patent Notice of Allowance for SDC-1802
PU
07/21Sareum Holdings plc Provides Financial Guidance for Fiscal 2021
CI
07/19FTSE 100 Closes Down as Covid Cases Rise
DJ
07/19ALAN JOPE : FTSE 100 Slides as Virus Jitters Weigh
DJ
07/19SAREUM : Subscription to raise £1,000,000
PU
07/01SAREUM : Completed Covid-19 Research Project Delivers Encouraging Results
PU
06/22SAREUM : to Present at BioTrinity 2021 Conference
PU
06/15FTSE 100 Closes Higher Boosted by Strenghtened US Economy
DJ
06/15FTSE Rises, Bellway's Share Price Looks Well Supported
DJ
06/15SAREUM : Subscription to raise £1,470,000
PU
06/01SAREUM : Subscription to Raise £900,000
PU
05/28Sareum Holdings plc Expands Production Capacities for Products for the Purification of ..
CI
05/25SAREUM : Trading Update
PU
05/13SAREUM : Exercise of Options and TVR
PU
05/05EDISON INVESTMENT RESEARCH LIMITED : Sareum Holdings (SAR): Treading the TYK2 trail
DJ
05/05SAREUM HOLDINGS (SAR) : Treading the TYK2 trail
DJ
04/23SAREUM : Half-year Report
PU
04/21Sareum Holdings plc Provides Financial Guidance for Fiscal 2021
CI
03/26SAREUM : Sareum Notes SRA737 Combination Data to be presented at the AACR Annual Meeting
AQ
03/25SAREUM : Interim Results Extension
PU
03/25SAREUM : Research Update
PU
02/16SAREUM : Notes New UK Government Covid-19 Initiative
PU
02/16Sareum Holdings plc Launched of Its AGILE Clinical Development Platform to Fund Phase 1..
CI
02/01SAREUM : to Present at the LSX World Congress 2021
PU
01/26SAREUM : to Participate in the Edison Open House
PU
01/11UPDATE RE : FLT3+Aurora Kinase Inhibitor Programme
PU
01/08Sareum Holdings plc Provides Update on FLT3+Aurora Kinase Inhibitor Programme
CI
01/07SAREUM : US Patent Grant for TYK2/JAK1 Anticancer Candidate
PU
01/07SAREUM : Shares Soared 11% On Patent Approval For Kinase Inhibitor Program Invention
MT
2020SAREUM : AGM Statement
AQ
2020SAREUM : AGM Statement
PU
2020European Stocks Close Higher on Monday as Post-Brexit Trade Deal Talks Continue, Lockdo..
MT
2020SAREUM : Nature Article Highlights Role of TYK2 in Covid-19
PU
2020SAREUM : Jumps 33% on New Discovery Supporting SDC-1801 Development Program in COVID-19
MT
2020Sareum Holdings plc Announces TYK2 as Key Causative Genetic Mechanism and Potential Tar..
CI
2020SAREUM : Covid-19 Research Grant Confirmed
PU
2020SAREUM : Gets UK Government Funds to Finance Study of Potential COVID-19 Therapy
MT
2020SAREUM : Notice of AGM
PU
2020SAREUM : Provides Update on Licensing Agreement Regarding SRA737, a Chk1 inhibitor in Clin..
AQ
2020SAREUM : Update on SRA737 Licensing Agreement
PU
2020SAREUM : Exercise of Share Options and Director Dealings
PU
2020SAREUM : Final results for the year ended 30 june 2020
AQ
2020SAREUM : Full Year Results Investor Presentation
PU
2020SAREUM : Final Results
PU
2020Sareum Holdings plc Reports Earnings Results for the Full Year Ended June 30, 2020
CI
2020US PATENT ALLOWANCE : SDC-1802 TYK2/JAK1 Inhibitor
PU
2020Sareum Holdings plc Announces That US Patent Allowance for Sareum's SDC-1802 TYK2/JAK1 ..
CI
2020SAREUM : Details of Investor Presentation
PU
2020SAREUM : Trading Statement
PU
2020SAREUM : Update on Deferred Salaries and Issue of Equity
PU
2020SAREUM : Successful Fundraising
PU
2020SAREUM : Placing to Raise £718,500
PU
2020SAREUM : to Present at BIO Bigital 2020
PU
2020SAREUM : BioTrinity Presentation Available Online
PU
2020SAREUM : Half-yearly results for the six months ended 31 december 2019
AQ
2020Pharma Company Enters into Licensing Agreement with Sareum Holdings
CI
2020SAREUM : Half-year Report
PU
2019SAREUM : notes Sierra Oncology Q3 2019 Results
PU
2019SAREUM : Research Update - SDC-1802 Anti-Cancer Poster
PU
2019SAREUM : Research Update - AACR-NCI-EORTC abstract
PU
2019SAREUM : Final Results for the Year Ended 30 June 2018
PU
2019Sareum Holdings plc Reports Earnings Results for the Full Year Ended June 30, 2019
CI
2019SAREUM : Notice of Full Year Results
PU
2019Sareum Holdings plc Announces Sareum TYK2/JAK1 Inhibitor SDC-1802 Demonstrates Anti-tum..
CI
2019SAREUM : Research Update - TYK2/JAK1 Cancer Programme
PU
2019SAREUM : Change of Adviser
PU
2019SAREUM : notes Sierra Q2 results
PU
2019SAREUM : Additional disclosure concerning Michael Owen
PU
2019SAREUM : Additional Funds Raised
PU
2019SAREUM : Sierra Seeks Strategic Options for SRA737
PU
2019SAREUM : Successful Fundraising
PU
2019SAREUM : PrimaryBid.com Offer
PU
1  2  3Next
Upcoming event on SAREUM HOLDINGS PLC